Preference-Weighted Health Status of PTSD Among Veterans: An Outcome for Cost-Effectiveness Analysis Using Clinical Data

被引:0
|
作者
Freed, Michael C. [1 ,2 ]
Yeager, Derik E. [3 ,4 ]
Liu, Xian [1 ,2 ]
Gore, Kristie L. [1 ,2 ]
Engel, Charles C. [1 ,2 ]
Magruder, Kathryn M. [3 ,4 ]
机构
[1] Walter Reed Army Med Ctr, Deployment Hlth Clin Ctr, Washington, DC 20307 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA
[3] Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
关键词
POSTTRAUMATIC-STRESS-DISORDER; PRIMARY-CARE; UTILITY MEASURES; METAANALYSIS; SYMPTOMS; PHARMACOTHERAPY; AFGHANISTAN; PREVALENCE; VALIDATION; CHECKLIST;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Posttraumatic stress disorder (PTSD) is a highly prevalent, chronic, disabling but treatable condition. Preference-based measures (for example, health utilities) are recommended for and useful in cost-effectiveness analyses and for policy decisions because they reflect a population's valuation of the desirability of disease states. However, no such measures exist for PTSD. This study aimed to estimate preference-weighted health status associated with PTSD and common co-occurring mental disorders in a sample of veterans by transforming health-related quality-of-life data into preference-weighted health status scores (PWHS scores), develop a usable regression model to predict PWHS scores from other data sets, and compare preference-weighted health status of PTSD with that of another chronic disorder, chronic obstructive pulmonary disease (COPD). Methods: A secondary analysis was performed on data from a random sample of 808 veterans (79% male; 12% met criteria for PTSD) in four primary care clinics. Veterans responded to the PTSD Checklist (PCL), Clinician-Administered PTSD Scale, Mini-International Neuropsychiatric Interview, and Medical Outcomes Survey Short Form-36. Results: PWHS scores were .029 lower among veterans with PTSD compared with veterans without PTSD, all else being equal. However, scores depended on PTSD severity, when the analysis controlled for other model variables. Specifically, PWHS scores dropped by .004 with a 1-unit increase in PCL scores among veterans without PTSD. Among veterans with PTSD, the reduction was .002. PTSD was associated with lower preference-weighted health status than COPD. Conclusions: This is the first study to estimate preference-weighted health status of persons with PTSD. These PWHS scores can be helpful in cost-effectiveness studies of PTSD treatments. (Psychiatric Services 60: 1230-1238, 2009)
引用
收藏
页码:1230 / 1238
页数:9
相关论文
共 50 条
  • [31] Clinical Effectiveness and Cost-Effectiveness of Oral-Health Promotion in Dental Caries Prevention among Children: Systematic Review and Meta-Analysis
    Fraihat, Nadine
    Madae'en, Saba
    Bencze, Zsuzsa
    Herczeg, Adrienn
    Varga, Orsolya
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (15)
  • [32] Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
    Oh, Sung-Hee
    Rhee, Chin Kook
    Bae, Eun Jin
    Ku, Hyemin
    HEALTH ECONOMICS REVIEW, 2024, 14 (01):
  • [33] A COST-EFFECTIVENESS ANALYSIS USING DATA ENVELOPMENT ANALYSIS - AN APPLICATION TO COLORECTAL-CANCER SCREENING
    DERVAUX, B
    EECKHOUDT, L
    LEBRUN, T
    SAILLY, JC
    MEDICAL DECISION MAKING, 1991, 11 (01) : 68 - 68
  • [34] Cost-effectiveness analysis of six triptans using data from a published meta-analysis
    Weis, K
    CEPHALALGIA, 2003, 23 (07) : 753 - 753
  • [35] Screening and Vaccination Against Measles and Varicella Among Health Care Workers: A Cost-effectiveness Analysis
    Lee, Ji-Suk
    Jeong, Oh
    Yang, Hyunju
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2021, 33 (05) : 508 - 515
  • [36] Clinical Effectiveness and Cost-Effectiveness of Somatropin Treatment for Short Children in Egypt: Analysis of 1-Year Data
    Ibrahim, Amany
    Atef, Abeer
    Badawy, Nora
    Helmy, Eatemad
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 442 - 442
  • [37] USING COST-EFFECTIVENESS ANALYSIS TO DEFINE THE CLINICAL-SIGNIFICANCE OF EFFECTIVENESS RATES IN THE PLANNING STAGES OF A CLINICAL-TRIAL
    DETSKY, AS
    MEDICAL DECISION MAKING, 1983, 3 (03) : 356 - 356
  • [38] Propensity Score Weighting Using Overlap Weights: A New Method Applied to Regorafenib Clinical Data and a Cost-Effectiveness Analysis
    Mlcoch, Tomas
    Hrnciarova, Tereza
    Tuzil, Jan
    Zadak, Jakub
    Marian, Marisca
    Dolezal, Tomas
    VALUE IN HEALTH, 2019, 22 (12) : 1370 - 1377
  • [39] COST-EFFECTIVENESS OF ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH UNCOMPLICATED HYPERTENSION: A COMPARATIVE ANALYSIS USING CLINICAL AND DRUGS UTILIZATION DATA
    Mazza, A.
    Schiavon, L.
    Rossetti, C.
    Sacco, A. P.
    Bregola, G.
    Contato, E.
    Ramazzina, E.
    JOURNAL OF HYPERTENSION, 2017, 35 : E211 - E211
  • [40] Clinical and cost-effectiveness analysis of using atorvastatin for secondary stroke prevention: a Spanish perspective
    Mar, J.
    Vivancos, J.
    Rejas, J.
    Arrospide, A.
    Caro, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S695 - S695